Models:
Joseph Gordon
joseph-gordon/
ClinicalAttritionRatePred
0
Downloads: 1
[6e0d8e]: / final_table1.csv

Download this file

# nct_id dropout_percentage_all Clinical Title Overall Status Trial Phase Allocation Start Date Completion Date Primary Purpose City State Zipcode Gender Minimum Age New Completion Date New Start Date length_of_trial RUCA2.0 Cleaned_Zipcodes
1 NCT00001596 17.39130435 Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome Completed Phase 2 Randomized September 2005 May 9, 2016 Treatment Bethesda Maryland 20892 All 18.0 2016-05-01 2005-09-01 3895.0 1.0 20892
2 NCT00001723 8.0 Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases Completed Phase 2 Randomized May 1998 October 2011 Treatment Bethesda Maryland 20892 All 12.0 2011-10-01 1998-05-01 4901.0 1.0 20892
3 NCT00003869 21.87789084 Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer Completed Phase 3 Randomized April 1999 May 2008 Treatment Rochester Minnesota 55905 All 18.0 2008-05-01 1999-04-01 3318.0 1.0 55905
4 NCT00003901 0.8595988539 Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery Completed Phase 3 July 1999 October 2011 Diagnostic Mobile Alabama 36608 All 18.0 2011-10-01 1999-07-01 4475.0 1.0 36608
5 NCT00045162 24.43651603 S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer Completed Phase 3 Randomized November 2002 December 2009 Treatment Anniston Alabama 36202 All 18.0 2009-12-01 2002-11-01 2587.0 1.0 36202
6 NCT00047385 1.406735931 National Lung Screening Trial (NLST) Screening Completed Phase 3 Randomized August 2002 October 2010 Screening Birmingham Alabama 35233 All 55.0 2010-10-01 2002-08-01 2983.0 1.0 35233
7 NCT00047463 13.63636364 Effects of Treating Obstructive Sleep Apnea in Epilepsy Completed Phase 2 Randomized September 2002 July 2008 Treatment Ann Arbor Michigan 48109 All 18.0 2008-07-01 2002-09-01 2130.0 1.0 48109
8 NCT00048997 7.975460123 Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer Completed Phase 3 Randomized September 2002 December 2016 Treatment Phoenix Arizona 85013 All 18.0 2016-12-01 2002-09-01 5205.0 1.0 85013
9 NCT00050960 40.19607843 Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Completed Phase 3 Randomized May 2002 March 2005 Treatment Montgomery Alabama 36106 All 18.0 2005-03-01 2002-05-01 1035.0 1.0 36106
10 NCT00051363 22.62039077 Apnea Positive Pressure Long-Term Efficacy Study Completed Phase 3 Randomized September 2002 September 2008 Treatment Tucson Arizona 85724 All 18.0 2008-09-01 2002-09-01 2192.0 1.0 85724
11 NCT00053846 12.92056595 Buspirone in Reducing Shortness of Breath in Patients With Cancer Completed Phase 2/Phase 3 Randomized November 2002 January 2011 Supportive Care Chicago Illinois 60612-7323 All 18.0 2011-01-01 2002-11-01 2983.0 1.0 60612
12 NCT00057746 0.5050505051 Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer Completed Phase 2 Randomized February 2003 November 2013 Treatment Birmingham Alabama 35294 All 18.0 2013-11-01 2003-02-01 3926.0 1.0 35294
13 NCT00057837 20.45454545 Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Completed Phase 2 Randomized July 14, 2004 August 2012 Treatment Lewes Delaware 19958 All 18.0 2012-08-01 2004-07-01 2953.0 4.0 19958
14 NCT00062010 0.0 Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer Completed Phase 2 May 26, 2004 August 2012 Treatment Decatur Georgia 30033 All 18.0 2012-08-01 2004-05-01 3014.0 1.0 30033
15 NCT00063154 25.58139535 Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy Completed Phase 2 July 2003 April 2005 Treatment Scottsdale Arizona 85258 All 18.0 2005-04-01 2003-07-01 640.0 1.0 85258
16 NCT00065429 4.87804878 Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer Completed Phase 1/Phase 2 Non-Randomized April 2003 December 2008 Treatment Denver Colorado 80218 All 18.0 2008-12-01 2003-04-01 2071.0 1.0 80218
17 NCT00066222 1.408450704 Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Completed Phase 2 June 2003 November 2013 Treatment Birmingham Alabama 35294 All 18.0 2013-11-01 2003-06-01 3806.0 1.0 35294
18 NCT00069823 2.246453945 Study of Acid Reflux in Asthma Completed Phase 3 Randomized September 2003 May 2008 Treatment Birmingham Alabama 35294 All 18.0 2008-05-01 2003-09-01 1704.0 1.0 35294
19 NCT00071032 0.8433040077 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease Completed Phase 3 Randomized July 2003 May 2009 Treatment New Brunswick New Jersey 08903 All 50.0 2009-05-01 2003-07-01 2131.0 1.0 08903
20 NCT00078312 46.64634146 Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder Completed Phase 3 Non-Randomized January 2004 July 2006 Treatment Peoria Arizona 85381 All 18.0 2006-07-01 2004-01-01 912.0 1.0 85381
21 NCT00079040 1.587301587 Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer Completed Phase 2 January 2006 January 2009 Treatment Boston Massachusetts 02215 All 18.0 2009-01-01 2006-01-01 1096.0 1.0 02215
22 NCT00079937 14.96609178 Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma Completed Phase 3 Randomized April 2004 March 2008 Treatment Birmingham Alabama 35209 All 6.0 2008-03-01 2004-04-01 1430.0 1.0 35209
23 NCT00080223 54.21686747 Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Completed Phase 2 August 31, 2003 April 30, 2015 Other Phoenix Arizona 85006 All 40.0 2015-04-01 2003-08-01 4261.0 1.0 85006
24 NCT00087438 0.0 Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer Completed Phase 2 May 2004 December 2016 Treatment Rochester New York 14642 All 18.0 2016-12-01 2004-05-01 4597.0 1.0 14642
25 NCT00087698 18.18181818 Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Completed Phase 2 Non-Randomized September 2003 February 2008 Treatment San Francisco California All 18.0 2008-02-01 2003-09-01 1614.0 1.0 94101
26 NCT00094094 21.875 Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer Completed Phase 2 February 2005 July 2007 Treatment Irvine California 92612 All 18.0 2007-07-01 2005-02-01 880.0 1.0 92612
27 NCT00095199 18.6503884 Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer Completed Phase 3 Randomized January 2005 July 2011 Treatment Birmingham Alabama 35294 All 18.0 2011-07-01 2005-01-01 2372.0 1.0 35294
28 NCT00096226 26.31578947 Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer Completed Phase 2 September 2004 May 16, 2016 Treatment Phoenix Arizona 85013 All 18.0 2016-05-01 2004-09-01 4260.0 1.0 85013
29 NCT00096486 6.477732794 Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer Completed Phase 1/Phase 2 May 2004 July 2010 Treatment New York New York 10021 All 18.0 2010-07-01 2004-05-01 2252.0 1.0 10021
30 NCT00097773 6.25 Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis Completed Phase 2 Randomized September 2004 August 2009 Prevention Birmingham Alabama 35233 All 18.0 2009-08-01 2004-09-01 1795.0 1.0 35233
31 NCT00098254 5.405405405 BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer Completed Phase 2 Non-Randomized December 2004 January 2011 Treatment Bethesda Maryland 20892 All 18.0 2011-01-01 2004-12-01 2222.0 1.0 20892
32 NCT00100932 21.97802198 Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy Completed Phase 2 Non-Randomized December 2004 Treatment Gilroy California All 18.0 2004-12-01 731.0 1.0 95020
33 NCT00102804 12.79340565 Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) Completed Phase 3 Randomized March 2005 December 2013 Treatment Minneapolis Minnesota 55455 All 18.0 2013-12-01 2005-03-01 3197.0 1.0 55455
34 NCT00103259 13.95881007 Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Completed Phase 2 Randomized July 2005 November 2011 Treatment Boston Massachusetts 02215 All 18.0 2011-11-01 2005-07-01 2314.0 1.0 02215
35 NCT00104520 52.59259259 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa Completed Phase 3 Randomized February 2005 September 2006 Treatment Phoenix Arizona All 6.0 2006-09-01 2005-02-01 577.0 1.0 13135
36 NCT00105183 5.188943886 EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection Completed Phase 3 Randomized January 2005 January 2011 Prevention Los Angeles California 90048 All 18.0 2011-01-01 2005-01-01 2191.0 1.0 90048
37 NCT00107952 5.361968834 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed Phase 3 Randomized February 2005 July 2007 Treatment Springfield Massachusetts 01199 All 18.0 2007-07-01 2005-02-01 880.0 1.0 01199
38 NCT00111839 26.26866917 Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer Completed Phase 2 Randomized May 31, 2005 March 31, 2009 Treatment Tucson Arizona 85715 All 18.0 2009-03-01 2005-05-01 1400.0 1.0 85715
39 NCT00112294 0.0 Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Completed Phase 3 Randomized December 2004 August 2008 Treatment Birmingham Alabama All 18.0 2008-08-01 2004-12-01 1339.0 1.0 35203
40 NCT00112359 24.19642857 International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa Completed Phase 3 Randomized May 2005 April 2007 Treatment Birmingham Alabama All 6.0 2007-04-01 2005-05-01 700.0 1.0 35203
41 NCT00113516 26.19047619 A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Completed Phase 2 Non-Randomized September 2005 March 2009 Treatment Los Angeles California 90048 All 18.0 2009-03-01 2005-09-01 1277.0 1.0 90048
42 NCT00117325 6.25181645 Study Of Adults And Adolescents With Vasomotor Rhinitis Completed Phase 3 Randomized July 11, 2005 February 9, 2006 Treatment Beverly Hills California 90212 All 12.0 2006-02-01 2005-07-01 215.0 1.0 90212
43 NCT00117572 4.396135266 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Completed Phase 3 Randomized November 2004 December 2016 Treatment Los Angeles California 90033 All 18.0 2016-12-01 2004-11-01 4413.0 1.0 90033
44 NCT00118703 4.031293602 Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis Completed Phase 3 Randomized July 1, 2005 February 9, 2006 Treatment Birmingham Alabama 35209 All 12.0 2006-02-01 2005-07-01 215.0 1.0 35209
45 NCT00124618 0.0 Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Completed Phase 2 January 2006 March 2015 Treatment Scottsdale Arizona 85259-5499 All 18.0 2015-03-01 2006-01-01 3346.0 1.0 85259
46 NCT00125359 11.9047619 Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer Completed Phase 2 August 2005 March 2014 Treatment Lebanon New Hampshire 03756 All 18.0 2014-03-01 2005-08-01 3134.0 1.0 03756
47 NCT00128492 25.13849984 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) Completed Phase 3 Non-Randomized August 2005 January 2009 Treatment Birmingham Alabama All 6.0 2009-01-01 2005-08-01 1249.0 1.0 35203
48 NCT00129766 1.62806476 Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children Completed Phase 3 Randomized November 2004 May 2006 Prevention Birmingham Alabama 35233 All 18.0 2006-05-01 2004-11-01 546.0 1.0 35233
49 NCT00138658 34.56790123 A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Completed Phase 1/Phase 2 November 2004 March 2010 Treatment Los Angeles California 90033 All 18.0 2010-03-01 2004-11-01 1946.0 1.0 90033
50 NCT00139659 19.38453318 A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma Completed Phase 3 Randomized January 2003 October 2008 Treatment Glendale Arizona 85306 All 18.0 2008-10-01 2003-01-01 2100.0 1.0 85306
51 NCT00144339 40.99070223 Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients Completed Phase 3 December 2002 Treatment Anniston Alabama All 40.0 2002-12-01 731.0 1.0 36201
52 NCT00147537 41.98247536 Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer Completed Phase 1/Phase 2 Randomized February 2005 August 2011 Treatment Tucson Arizona 85719 All 18.0 2011-08-01 2005-02-01 2372.0 1.0 85719
53 NCT00159913 2.673160173 A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension. Completed Phase 3 Randomized August 2003 June 2008 Treatment Palo Alto California 94304 All 18.0 2008-06-01 2003-08-01 1766.0 1.0 94304
54 NCT00168831 25.35410676 Tiotropium / Respimat One-Year Study Completed Phase 3 Randomized February 2003 Treatment Birmingham Alabama All 40.0 2003-02-01 731.0 1.0 35203
55 NCT00168844 20.55305863 Tiotropium / Respimat One-Year Study Completed Phase 3 Randomized January 2003 Treatment Los Angeles California All 40.0 2003-01-01 731.0 1.0 90001
56 NCT00171834 45.71428571 Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer Completed Phase 1/Phase 2 Non-Randomized August 2003 September 2008 Treatment Louisville Kentucky 40232-5070 All 18.0 2008-09-01 2003-08-01 1858.0 1.0 40232
57 NCT00182689 32.25146199 Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer Completed Phase 2 July 2005 October 2008 Treatment Portland Oregon 97239 All 18.0 2008-10-01 2005-07-01 1188.0 1.0 97239
58 NCT00191139 21.875 Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) Completed Phase 2 Randomized March 2003 February 2009 Treatment Denver Colorado 80218 All 18.0 2009-02-01 2003-03-01 2164.0 1.0 80218
59 NCT00200967 13.96825397 Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Completed Phase 3 Randomized December 2004 February 2008 Treatment San Diego California 92103 All 18.0 2008-02-01 2004-12-01 1157.0 1.0 92103
60 NCT00207740 23.05019542 A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma Completed Phase 2 Randomized August 2004 July 2007 Treatment Los Angeles California All 18.0 2007-07-01 2004-08-01 1064.0 1.0 90001
61 NCT00216203 6.060606061 Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Completed Phase 1/Phase 2 May 2005 December 2008 Treatment Galesburg Illinois 61401 All 18.0 2008-12-01 2005-05-01 1310.0 4.0 61401
62 NCT00227539 4.0 Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Completed Phase 2 July 2005 November 2013 Treatment Seattle Washington 98109-1023 All 18.0 2013-11-01 2005-07-01 3045.0 1.0 98109
63 NCT00228553 47.60601915 Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness Completed Phase 3 Non-Randomized May 2004 July 2006 Treatment Birmingham Alabama 35213 All 18.0 2006-07-01 2004-05-01 791.0 1.0 35213
64 NCT00228566 21.05263158 Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome Completed Phase 3 Non-Randomized October 2005 July 2006 Treatment Birmingham Alabama 35213 All 18.0 2006-07-01 2005-10-01 273.0 1.0 35213
65 NCT00231465 4.545454545 Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer Completed Phase 2 July 2003 August 2012 Treatment Tampa Florida 33612 All 70.0 2012-08-01 2003-07-01 3319.0 1.0 33612
66 NCT00232557 5.958829902 Telecommunications System in Asthma Completed Phase 3 Randomized August 2004 December 2009 Treatment Boston Massachusetts 02130 All 18.0 2009-12-01 2004-08-01 1948.0 1.0 02130
67 NCT00243074 21.27659574 S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery Completed Phase 2 November 2005 December 2011 Treatment San Antonio Texas 78245 All 18.0 2011-12-01 2005-11-01 2221.0 1.0 78245
68 NCT00244725 7.650205539 Odiparcil For The Prevention Of Venous Thromboembolism Completed Phase 2 Randomized September 2005 September 2006 Prevention Birmingham Alabama 35209 All 35.0 2006-09-01 2005-09-01 365.0 1.0 35209
69 NCT00247416 5.225806452 Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer Completed Phase 2 Randomized August 2005 July 2009 Treatment Danville Kentucky 40422 All 18.0 2009-07-01 2005-08-01 1430.0 4.0 40422
70 NCT00248495 2.631578947 Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Completed Phase 2 June 8, 2005 April 5, 2017 Treatment Buffalo New York 14263-0001 All 18.0 2017-04-01 2005-06-01 4322.0 1.0 14263
71 NCT00250679 27.30371791 Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease Completed Phase 3 Randomized October 2005 October 2007 Treatment Birmingham Alabama 33744 All 35.0 2007-10-01 2005-10-01 730.0 1.0 33744
72 NCT00255047 8.861391361 Safety and Immune Response of Different Pediatric Combination Vaccines. Completed Phase 3 Randomized November 2005 February 2009 Prevention Tuscaloosa Alabama 35401 All 18.0 2009-02-01 2005-11-01 1188.0 1.0 35401
73 NCT00257608 14.27432795 A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) Completed Phase 3 Randomized January 2006 November 2014 Treatment Mobile Alabama 36608 All 18.0 2014-11-01 2006-01-01 3226.0 1.0 36608
74 NCT00258895 1.952619971 Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® Completed Phase 3 Non-Randomized March 2005 April 2007 Prevention Fayetteville Arkansas 15213 All 4.0 2007-04-01 2005-03-01 761.0 1.0 15213
75 NCT00261833 11.80941787 Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency Completed Phase 4 Randomized March 2006 September 2012 Treatment Denver Colorado 80206 All 18.0 2012-09-01 2006-03-01 2376.0 1.0 80206
76 NCT00264576 0.3262720886 Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults Completed Phase 2 Randomized October 2005 May 2006 Prevention Bardstown Kentucky 40004 All 18.0 2006-05-01 2005-10-01 212.0 4.2 40004
77 NCT00265317 19.72445465 A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone Completed Phase 2 Randomized June 2006 January 2012 Treatment Birmingham Alabama 35233 All 18.0 2012-01-01 2006-06-01 2040.0 1.0 35233
78 NCT00266877 14.98778999 Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer Completed Phase 2 Non-Randomized December 2005 January 2009 Treatment Los Angeles California 90033 All 18.0 2009-01-01 2005-12-01 1127.0 1.0 90033
79 NCT00267202 21.11722387 Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma Completed Phase 4 Randomized December 2005 April 2008 Treatment East Hanover New Jersey All 18.0 2008-04-01 2005-12-01 852.0 1.0 07936
80 NCT00279916 13.21256039 Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays Completed Phase 3 Randomized September 1, 2005 March 2009 Treatment Rochester Minnesota 55905 All 6.0 2009-03-01 2005-09-01 1277.0 1.0 55905
81 NCT00280735 20.83333333 Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC Completed Phase 2 May 2004 July 2011 Treatment Chapel Hill North Carolina 27599 All 18.0 2011-07-01 2004-05-01 2617.0 1.0 27599
82 NCT00282295 2.088680709 US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease Completed Phase 4 Randomized January 25, 2006 August 8, 2006 Prevention Chandler Arizona 85224 All 11.0 2006-08-01 2006-01-01 212.0 1.0 85224
83 NCT00283244 24.70291147 Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC Completed Phase 2 Randomized March 2006 October 2014 Treatment Fayetteville Arkansas 72703 All 70.0 2014-10-01 2006-03-01 3136.0 1.0 72703
84 NCT00284141 32.65306122 Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma Completed Phase 2 Non-Randomized January 2006 July 2008 Treatment Bridgewater New Jersey 08807 All 18.0 2008-07-01 2006-01-01 912.0 1.0 08807
85 NCT00285012 33.04202545 Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD). Completed Phase 3 Randomized May 2006 April 2009 Treatment Birmingham Alabama 35249-2181 All 35.0 2009-04-01 2006-05-01 1066.0 1.0 35249
86 NCT00289198 19.20529801 Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) Completed Phase 3 Randomized February 7, 2006 July 4, 2006 Treatment San Diego California 92123 All 12.0 2006-07-01 2006-02-01 150.0 1.0 92123
87 NCT00289783 10.46572005 Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine Completed Phase 3 Randomized February 22, 2006 February 26, 2008 Prevention Birmingham Alabama 35216 All 18.0 2008-02-01 2006-02-01 730.0 1.0 35216
88 NCT00294762 4.19600939 Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC Completed Phase 2 Randomized January 2006 March 2009 Treatment Alhambra California 91801 All 18.0 2009-03-01 2006-01-01 1155.0 1.0 91801
89 NCT00296491 13.23477627 Study Of Allergic Rhinitis In Patients Who Also Have Asthma Completed Phase 4 Randomized September 2005 October 2007 Treatment Birmingham Alabama 35209 All 15.0 2007-10-01 2005-09-01 760.0 1.0 35209
90 NCT00298896 7.272727273 Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer Completed Phase 2 February 2006 June 2008 Treatment Sacramento California 95817 All 18.0 2008-06-01 2006-02-01 851.0 1.0 95817
91 NCT00301366 2.631578947 The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency Completed Phase 3 Non-Randomized June 2006 March 2007 Treatment Denver Colorado 80206 All 18.0 2007-03-01 2006-06-01 273.0 1.0 80206
92 NCT00301808 17.24137931 Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer Completed Phase 2 November 2005 October 2012 Treatment Detroit Michigan 48201-1379 All 18.0 2012-10-01 2005-11-01 2526.0 1.0 48201
93 NCT00303459 24.40790656 Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Completed Phase 4 Randomized May 2006 December 2013 Treatment La Jolla California 92037-7381 All 12.0 2013-12-01 2006-05-01 2771.0 1.0 92037
94 NCT00309907 10.25641026 Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Completed Phase 2 April 2006 September 2011 Treatment Birmingham Alabama 35294 All 18.0 2011-09-01 2006-04-01 1979.0 1.0 35294
95 NCT00309946 1.960784314 Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery Completed Phase 2 December 2005 September 2010 Treatment Chicago Illinois 60637-1470 All 18.0 2010-09-01 2005-12-01 1735.0 1.0 60637
96 NCT00312377 6.396598845 ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer Completed Phase 3 Randomized May 2006 March 2014 Treatment Fullerton California All 18.0 2014-03-01 2006-05-01 2861.0 1.0 58441
97 NCT00316186 24.24242424 First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin Completed Phase 2 Non-Randomized June 2005 May 2009 Treatment Tucson Arizona 85712 All 18.0 2009-05-01 2005-06-01 1430.0 1.0 85712
98 NCT00317044 13.84869562 Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma Completed Phase 2 Randomized April 2006 July 2008 Treatment Birmingham Alabama All 18.0 2008-07-01 2006-04-01 822.0 1.0 35203
99 NCT00319020 38.0952381 Bosentan in Children With Pulmonary Arterial Hypertension Extension Study Completed Phase 3 August 23, 2005 October 28, 2011 Treatment Denver Colorado 80218 All 2.0 2011-10-01 2005-08-01 2252.0 1.0 80218
100 NCT00319111 21.85430464 Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Completed Phase 3 Non-Randomized January 2006 April 2009 Treatment La Jolla California 92037-1300 All 18.0 2009-04-01 2006-01-01 1186.0 1.0 92037